Health and Women's Health Stocks

See below for the full list of every health and women's health stock in Carbon Collective's Climate Index.

Securing access to voluntary family planning can reduce overall carbon footprint.

Some 225 million women in lower-income countries say they want the ability to choose whether and when to become pregnant but don't have access to contraception. The result? Some 75 million unintended pregnancies each year.

Many people in high-income countries don't have access to contraceptives, either. 45% of pregnancies are unintended in the United States, for example. Securing the right to voluntary, high-quality family planning services around the world would have significant positive impacts on the health, welfare, and life expectancy of both women and their children.

Every person on Earth consumes resources and causes emissions throughout their lifetime. If family planning services are made widely available worldwide and if every boy and girl in the world are given equal quality education, the reduced population size could avoid 85.42 gigatons of CO2 equivalent from 2020 and 2050.

It's not about government control over reproduction. It's about access to voluntary family planning.

The topic of limiting population growth is not often discussed because it invokes fears about coercive or cruel efforts by centralized governments to force the birth rate down (or up).

But this Drawdown solution is the polar opposite. It's about giving women the right to choose whether or not to have children and to plan her future. The right to family planning - through education about sex and reproduction, easy access to contraception, and accommodating social and religious norms about birth control - can meet women's expressed needs, empowerment, equality, and well-being. Benefits to the environment and climate are welcome side effects.

That said, challenges to expanding access to family planning do exist. Many communities don't have basic supply of affordable and culturally appropriate contraception. Education about sex and reproduction isn't available. Health clinics are sparse.

Currently, the world is $5.3 billion short in funding access to reproductive healthcare that women say they want to have.

Companies can help fill this gap.

The women's health stocks in the Climate Index can help fill this gap. If at least 50% of a company's revenue comes from contraceptive products, they make it into the Index. And as always, we exclude penny stocks whose share prices were less than $0.50 in our last update.

If you are a Carbon Collective member, you own all of these companies through the Climate Index.

Filters:

Index Status:

Pure Play

Passed Exclusionary Filter

Failed Exclusionary Filter

Lacks Proper Information

% ALLOCATED	Company Type	Company	Category	DESCRIPTION
-	Contraceptives	Abbvie	Failed Contraceptive Filter	Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
0.02%	Contraceptives	Agile Therapeutics	Pure Play	Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
-	Contraceptives	Church & Dwight	Failed Contraceptive Filter	Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
0.02%	Contraceptives	Evofem Biosciences	Pure Play	Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
-	Contraceptives	Merck & Co	Failed Contraceptive Filter	Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
-	Contraceptives	ObsEva SA	No Drawdown Solution	ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
-	Contraceptives	Pfizer	Lacks Sufficient Information	It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
-	Contraceptives	Teva Pharmaceutical Industries	Lacks Sufficient Information	It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
-	Contraceptives	The Cooper Companies	Failed Contraceptive Filter	Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
-	Contraceptives	TherapeuticsmMD	Lacks Sufficient Information	It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
0.03%	Contraceptives	Veru	Passed Contraceptive Filter	Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.

Health and Women's Health Stocks

Family Planning and Women's Health Stocks in the Climate Index

Filters:

Watch the Webinar

Get Our Newsletter

Talk To A Human